ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
104,698.55
-0.03%
S&P 500
6,101.24
-0.29%
Dow Jones
44,424.25
-0.32%
US Dollar vs Yen
155.995
0.00%
Brent Oil
77.625
0.00%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ

  6. Embecta Corporation (EMBC) 銘柄情報

Embecta Corporation

Embecta Corporation (EMBC)

NASDAQ
18.96
-0.17
(-0.89%)
終了 1月27日 6:00AM
15分遅延
18.96
-0.005
(-0.03%)
取引時間後: 7:30AM
15分遅延

個人投資家向けのプロ仕様のツール。

プレミアム

主要統計と詳細

通貨
18.96
買値
18.10
売値
20.00
出来高
233,269
18.59 日の範囲 19.2431
9.925 52 週間の範囲 21.48
時価総額
1.102B
前日終値
19.13
始値
19.06
時刻
1
@
18.7
最終取引時間
財務取引量
US$ 4,424,636
VWAP
18.968
平均取引量 (3 か月)
434,861
発行済株式数
58,130,561
配当利回り
3.16%
PER
14.08
1 株当たり利益 (EPS)
1.35
歳入
1.12B
純利益
78.3M

Embecta Corporation について

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others. Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

セクター
Surgical,med Instr,apparatus
業界
Surgical,med Instr,apparatus
ウェブサイト
www.embecta.com
本社
Wilmington, Delaware, USA
設立
-
Embecta Corporation is listed in the Surgical,med Instr,apparatus sector of the ナスダック市場 with ticker EMBC. The last closing price for Embecta was US$19.13. Over the last year, Embecta shares have traded in a share price range of US$ 9.925 to US$ 21.48.

Embecta currently has 58,130,561 shares in issue. The market capitalisation of Embecta is US$1.11 billion. Embecta has a price to earnings ratio (PE ratio) of 14.08.

EMBC 最新ニュース

その他のニュース

embecta to Report Fiscal First Quarter 2025 Financial Results

PARSIPPANY, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference...

2025年1月24日
GlobeNewswire Inc.

embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference

PARSIPPANY, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco...

2024年12月20日
GlobeNewswire Inc.

Form ARS - Annual Report to Security Holders

2024年12月20日
Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

2024年12月20日
Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements

2024年12月20日
Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

2024年12月12日
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

2024年12月5日
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

2024年12月5日
Edgar (US Regulatory)

Form 8-K - Current report

2024年12月3日
Edgar (US Regulatory)

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

2024年11月30日
Edgar (US Regulatory)
期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.050.26441036488618.9119.163418.1137102418.67654898CS
4-1.73-8.3615273078820.6921.2318.1141335119.85464099CS
124.7133.052631578914.2521.4813.0543486118.60763035CS
262.8617.763975155316.121.4812.4239702116.63320923CS
521.911.137162954317.0621.489.92541445014.9541412CS
156-13.4-41.409147095232.3636.649.92561412623.56268889CS
260-13.4-41.409147095232.3636.649.92561412623.56268889CS

EMBC - Frequently Asked Questions (FAQ)

What is the current Embecta share price?
The current share price of Embecta is US$ 18.96
How many Embecta shares are in issue?
Embecta has 58,130,561 shares in issue
What is the market cap of Embecta?
The market capitalisation of Embecta is USD 1.11B
What is the 1 year trading range for Embecta share price?
Embecta has traded in the range of US$ 9.925 to US$ 21.48 during the past year
What is the PE ratio of Embecta?
The price to earnings ratio of Embecta is 14.08
What is the cash to sales ratio of Embecta?
The cash to sales ratio of Embecta is 0.98
What is the reporting currency for Embecta?
Embecta reports financial results in USD
What is the latest annual turnover for Embecta?
The latest annual turnover of Embecta is USD 1.12B
What is the latest annual profit for Embecta?
The latest annual profit of Embecta is USD 78.3M
What is the registered address of Embecta?
The registered address for Embecta is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Embecta website address?
The website address for Embecta is www.embecta.com
Which industry sector does Embecta operate in?
Embecta operates in the SURGICAL,MED INSTR,APPARATUS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
NVNINVNI Group Ltd
US$ 4.38
(193.96%)
366.98M
EVAXEvaxion Biotech AS
US$ 5.99
(64.56%)
55.41M
ELABPMGC Holdings Inc
US$ 3.0901
(56.07%)
76.48M
PCLAPicoCELA Inc
US$ 4.60
(49.35%)
3.75M
GOEVCanoo Inc
US$ 0.475
(43.94%)
282.22M
GODNUGolden Star Acquisition Corporation
US$ 3.11
(-75.82%)
17.51k
GODNGolden Star Acquisition Corporation
US$ 2.93
(-65.67%)
902.76k
NXTTNext Technology Holding Inc
US$ 1.37
(-54.93%)
2.56M
SGLYSingularity Future Technology Ltd
US$ 1.625
(-38.45%)
917.77k
WHLRLWheeler Real Estate Investment Trust Inc
US$ 90.11
(-38.07%)
8
ACONAclarion Inc
US$ 0.0557
(28.94%)
811.91M
NVNINVNI Group Ltd
US$ 4.38
(193.96%)
366.98M
RIMEAlgorhythm Holdings Inc
US$ 0.0357
(4.69%)
284.97M
GOEVCanoo Inc
US$ 0.475
(43.94%)
282.22M
NVDANVIDIA Corporation
US$ 142.62
(-3.12%)
232.88M

EMBC Discussion

投稿を表示

最近閲覧した銘柄

NASDAQ
EMBC
Embecta
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有